Pooyeh Graili

(Founder & Principal)

Pooyeh is an MD, MBE, MPH (Health Economics & Health Promotion) with expertise in Health Technology Assessment (HTA), Digital Health (DH), Real-World Evidence (RWE), health policy, and Health Economics and Outcomes Research (HEOR). She has over 15 years of experience in governmental organizations, pharmaceutical companies (market access and medical affairs), consulting firms, private clinics, academia, health care, and research centers internationally (North America, Asia, and Europe).

Her experience in RWE, outcomes research, submissions to HTA bodies and public payers, comparative effectiveness, and scientific research covers a wide range of therapeutic areas. Pooyeh’s past experience in developing market access strategies, DH, and medical practice contributes to her knowledge base. She presented her research at international conferences and symposia, including ISPOR, CADTH, SMDM, ARCC, RSNA, CAPT and the 2nd World Congress of Thoracic Imaging and Diagnosis in Chest Disease. Her last publications in peer-reviewed journals focused on HTA, DH, outcomes research, AI, RWE and drug policy. She has reviewed DH, AI, and RWE articles for peer-reviewed journals such as npj Digital Medicine, Value in Health, and Frontiers as well as scientific abstracts for ISPOR, HTAi, CADTH, CAHSPR symposia and congresses.

Pooyeh’s company, “Quality HTA”, was established to address your need by integrating creativity and expertise into your decision-making to accelerate patient access to the right innovative technologies and improve care. Quality HTA is committed to delivering high-quality results in a timely manner.